Publication: DRUG REPURPOSING FOR TREATING LUPUS NEPHRITIS BASED ON TRANSCRIPTOME PROFILING AND AUTOIMMUNITY-RELATED SEROLOGICAL MARKERS
dc.contributor.author | Parodis, I. | |
dc.contributor.author | Lindblom, J. | |
dc.contributor.author | Toro-Dominguez, D. | |
dc.contributor.author | Borghi, M. O. | |
dc.contributor.author | Enman, Y. | |
dc.contributor.author | Repsilber, D. | |
dc.contributor.author | Mohan, C. | |
dc.contributor.author | Alarcon-Riquelme, M. | |
dc.contributor.author | Barturen, G. | |
dc.contributor.authoraffiliation | [Parodis, I.] Karolinska Inst, Div Rheumatol, Dept Med Solna, Stockholm, Sweden | |
dc.contributor.authoraffiliation | [Lindblom, J.] Karolinska Inst, Div Rheumatol, Dept Med Solna, Stockholm, Sweden | |
dc.contributor.authoraffiliation | [Enman, Y.] Karolinska Inst, Div Rheumatol, Dept Med Solna, Stockholm, Sweden | |
dc.contributor.authoraffiliation | [Parodis, I.] Orebro Univ, Fac Med & Hlth, Dept Rheumatol, Orebro, Sweden | |
dc.contributor.authoraffiliation | [Toro-Dominguez, D.] Univ Granada, Ctr Gen & Oncol Res Pfizer, GENYO, Granada, Spain | |
dc.contributor.authoraffiliation | [Alarcon-Riquelme, M.] Univ Granada, Ctr Gen & Oncol Res Pfizer, GENYO, Granada, Spain | |
dc.contributor.authoraffiliation | [Barturen, G.] Univ Granada, Ctr Gen & Oncol Res Pfizer, GENYO, Granada, Spain | |
dc.contributor.authoraffiliation | [Borghi, M. O.] Univ Milan, Milan, Italy | |
dc.contributor.authoraffiliation | [Borghi, M. O.] Ist Auxol Italiano, Dept Clin Sci & Community Hlth, Milan, Italy | |
dc.contributor.authoraffiliation | [Repsilber, D.] Orebro Univ, Sch Med Sci, Orebro, Sweden | |
dc.contributor.authoraffiliation | [Mohan, C.] Univ Houston, Dept Biomed Engn, Houston, TX USA | |
dc.date.accessioned | 2023-05-03T13:31:01Z | |
dc.date.available | 2023-05-03T13:31:01Z | |
dc.date.issued | 2022-06-01 | |
dc.identifier.doi | 10.1136/annrheumdis-2022-eular.5348 | |
dc.identifier.essn | 1468-2060 | |
dc.identifier.issn | 0003-4967 | |
dc.identifier.unpaywallURL | https://ard.bmj.com/content/annrheumdis/81/Suppl_1/326.2.full.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/20127 | |
dc.identifier.wosID | 850279001126 | |
dc.issue.number | 1 | |
dc.journal.title | Annals of the rheumatic diseases | |
dc.journal.titleabbreviation | Ann. rheum. dis. | |
dc.language.iso | en | |
dc.organization | Centro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica-GENYO | |
dc.page.number | 326-326 | |
dc.publisher | Bmj publishing group | |
dc.rights.accessRights | open access | |
dc.title | DRUG REPURPOSING FOR TREATING LUPUS NEPHRITIS BASED ON TRANSCRIPTOME PROFILING AND AUTOIMMUNITY-RELATED SEROLOGICAL MARKERS | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 81 | |
dc.wostype | Meeting Abstract | |
dspace.entity.type | Publication |